Clinical Trials Logo

Homonymous Hemianopia clinical trials

View clinical trials related to Homonymous Hemianopia.

Filter by:
  • None
  • Page 1

NCT ID: NCT06136169 Not yet recruiting - Clinical trials for Homonymous Hemianopia

Reminder-cue Scanning Training for Homonymous Visual Field Loss

Start date: May 2024
Phase: N/A
Study type: Interventional

This study will evaluate a new approach to training people with visual field loss to scan when driving

NCT ID: NCT06115317 Enrolling by invitation - Clinical trials for Homonymous Hemianopia

Homonymous Hemianopia in Childhood

HHIC
Start date: May 4, 2023
Phase: N/A
Study type: Interventional

The study will consist of two connected components at a single centre. Phase 1 is observational, phenotyping children with Homonymous hemianopia (HH). Phase 2 is a pilot double blind cross over RCT in which segmental prisms are compared with sham prisms in glasses.

NCT ID: NCT05141604 Recruiting - Hemianopsia Clinical Trials

Feasibility Test of Virtual Reality Obstacle Detection for Low Vision Walking

Start date: May 17, 2022
Phase: N/A
Study type: Interventional

The investigators are developing a new test of pedestrian hazard detection in virtual reality (VR) head-mounted display (HMD) headset, which shows virtual oncoming pedestrians in 3D while subjects are walking in real-world environment, for evaluation of visual field expansion to improve mobility in people with visual field loss.

NCT ID: NCT04827147 Recruiting - Clinical trials for Homonymous Hemianopia

Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia

Start date: October 3, 2022
Phase: N/A
Study type: Interventional

This clinical trial will evaluate the efficacy of two types of high-power prism glasses that provide field of view expansion for patients with homonymous hemianopia (the complete loss of half the field of vision on the same side in both eyes).

NCT ID: NCT04798924 Recruiting - Stroke, Ischemic Clinical Trials

Visual Rehabilitation After Occipital Stroke

Start date: July 19, 2021
Phase: N/A
Study type: Interventional

This research aims to examine changes in plastic potential of the visual system with time from stroke affecting primary visual cortex. We will measure structural and mechanistic aspects of progressive degeneration along the early visual pathways, correlating them with changes in visual performance, and in responsiveness to visual restoration training. This project will advance both scientific knowledge, as well as technical capability and clinical practices for restoring vision and quality of life for people suffering from cortical blindness.

NCT ID: NCT01372332 Completed - Clinical trials for Homonymous Hemianopia

Assessment of Homonymous Visual Loss and Its Impact on Visual Exploration, Activities of Daily Living (ADL) and Quality of Life (QoL)

Hemi-Drive
Start date: June 2011
Phase: N/A
Study type: Observational

The purpose of this explorative study, targeting subjects with homonymous visual field loss, is threefold: (i) to identify the perimetric / psychophysical method, that is most closely correlated with an individually assessed quality of life (QoL) score, using a validated questionnaire (NEI-VFQ 25) (ii) to determine, whether gaze-related (exploratory eye movements) or visual field-related (eyes steadily fixating) parameters are better for the characterization of the visual capacities that are necessary for activities of daily living (ADL), as represented by (iia) a standardized visual search task ("supermarket special offer search task") (iib) by an on-road car driving pilot study.

NCT ID: NCT00494676 Completed - Clinical trials for Homonymous Hemianopia

Clinical Trial of Peripheral Prism Glasses for Hemianopia

Start date: September 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the functional utility for general mobility (walking) of new high power permanent peripheral prism glasses, which provide visual field expansion device for patients with homonymous hemianopia (the complete loss of half the field of vision on the same side in both eyes). The efficacy of real peripheral prism glasses will be assessed relative to sham peripheral prism glasses.